CLINICAL_TRIALS
trial_result
· 2020-01-21
Clinical Trial Update: Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2) [Phase 3]
Summary
Phase 3 long-term study of lemborexant in insomnia disorder completed with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Inc. | Conditions: Insomnia Disorder | Phase 3 | Status: COMPLETED | Results posted: 2020-01-21